المؤلفون: Yuan Liu, Hao Wu, Yaodong Sang, Wei Chong, Liang Shang, Leping Li

المصدر: Discover Oncology, Vol 15, Iss 1, Pp 1-18 (2024)

مصطلحات موضوعية: Exosome, Angiogenesis, Antiangiogenic therapy, Digestive system tumour, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2730-6011Test

الوصول الحر: https://doaj.org/article/a2baf2e268734e6e801f4f6447541881Test

المؤلفون: Shuo Li, Ze‐Shun Yu, Hong‐Zhi Liu, Shu‐Jing Li, Ming‐Yue Wang, Fang‐Ling Ning, Li‐Jun Tian

المصدر: Cancer Medicine, Vol 13, Iss 11, Pp n/a-n/a (2024)

مصطلحات موضوعية: antiangiogenic therapy, Eastern Cooperative Oncology Group, immunotherapy, non‐small cell lung cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2045-7634Test

الوصول الحر: https://doaj.org/article/c001466037fc41159902e9418aed9281Test

المؤلفون: Yu Fang, Ning Su, Qihua Zou, Yi Cao, Yi Xia, Linquan Tang, Xiaopeng Tian, Panpan Liu, Qingqing Cai

المصدر: BMC Medicine, Vol 21, Iss 1, Pp 1-10 (2023)

مصطلحات موضوعية: Anlotinib, Nasopharyngeal carcinoma, Recurrent, Metastatic, Antiangiogenic therapy, Medicine

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1741-7015Test

الوصول الحر: https://doaj.org/article/f3ad912b778d43a28bad4a7408f60589Test

المؤلفون: Xin Qiu, Changchang Lu, Huizi Sha, Yahui Zhu, Weiwei Kong, Fan Tong, Qiaoli Wang, Fanyan Meng, Baorui Liu, Juan Du

المصدر: Frontiers in Immunology, Vol 15 (2024)

مصطلحات موضوعية: advanced pancreatic cancer, liver metastasis, S-1, immunotherapy, antiangiogenic therapy, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fimmu.2024.1210859/fullTest; https://doaj.org/toc/1664-3224Test

الوصول الحر: https://doaj.org/article/968ca30dc53f41aaab59602b600da29cTest

المؤلفون: Ljubicic Lidija, Janzic Urska, Unk Mojca, Terglav Ana Sophie, Mohorcic Katja, Seiwerth Fran, Bitar Lela, Badovinac Sonja, Plestina Sanja, Korsic Marta, Kukulj Suzana, Samarzija Miroslav, Jakopovic Marko

المصدر: Radiology and Oncology, Vol 57, Iss 3, Pp 397-404 (2023)

مصطلحات موضوعية: advanced nsclc, antiangiogenic therapy, docetaxel, nintedanib, real-world data, Medical physics. Medical radiology. Nuclear medicine, R895-920

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1581-3207Test

الوصول الحر: https://doaj.org/article/956b32553a3347c1bdae4e7034beddb4Test

المؤلفون: Xingxiang Pu, Gen Lin, Maoliang Xiao, Jie Lin, Qianzhi Wang, Yi Kong, Xuejun Yan, Fang Xu, Yan Xu, Jia Li, Kang Li, Bolin Chen, Xiaoping Wen, Yali Tan, Fengzhuo Cheng, Kangle Zhu, Na Li, Lin Wu

المصدر: EClinicalMedicine, Vol 67, Iss , Pp 102403- (2024)

مصطلحات موضوعية: Advanced non-small cell lung cancer (NSCLC), Platinum-free chemotherapy, Immunotherapy, Antiangiogenic therapy, Efficacy, Safety, Medicine (General), R5-920

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2589537023005801Test; https://doaj.org/toc/2589-5370Test

الوصول الحر: https://doaj.org/article/bd7cf6b86de74344ba804c838845cf40Test

المؤلفون: V. G. Likhvantseva, A. S. Gevorgyan, S. G. Kapkova, S. I. Rychkova, T. E. Borisenko, В. Г. Лихванцева, А. С. Геворкян, С. Г. Капкова, С. И. Рычкова, Т. Е. Борисенко

المصدر: Ophthalmology in Russia; Том 21, № 1 (2024); 117-127 ; Офтальмология; Том 21, № 1 (2024); 117-127 ; 2500-0845 ; 1816-5095 ; 10.18008/1816-5095-2024-1

مصطلحات موضوعية: офтальмогипертензия, antiangiogenic therapy, risk factor for poor response to treatment, arterial hypertension, ophthalmohypertension, антиангиогенная терапия, фактор риска плохого ответа на лечение, артериальная гипертензия

وصف الملف: application/pdf

العلاقة: https://www.ophthalmojournal.com/opht/article/view/2301/1195Test; Sperduto RD, Hiller R. Systemic hypertension and age-related maculopathy in the Framingham Study. Archives of ophthalmology. 1986;104(2):216–219. doi:10.1001/archopht.1986.01050140070022.; van Leeuwen R, Ikram MK, Vingerling JR, Witteman JCM, Hofman A, de Jong PTVM. Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. Investigative ophthalmology & visual science. 2003;44(9):3771–3777. doi:10.1167/iovs.03-0121.; Klein R, Klein BEK, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 2003;110(4):636–643. doi:10.1016/S01616420(02)01448-3.; Tan JSL, Mitchell P, Smith W, Wang JJ. Cardiovascular risk factors and the longterm incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology. 2007;114(6):1143–1150. doi:10.1016/j.ophtha.2006.09.033.; Park SJ, Lee JH, Woo SJ, Ahn J, Shin JP, Song SJ, Kang SW, Park KH; Age-related macular degeneration: prevalence and risk factors from Korean National Health and Nutrition Examination Survey, 2008 through 2011. Ophthalmology. 2014;121(9):1756–1765. doi:10.1016/j.ophtha.2014.03.022.; Klein R, Klein BE, Jensen SC, Cruickshanks KJ, Lee KE, Danforth LG, Tomany SC. Medication use and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. Archives of Ophthalmology. 2001;119(9):1354–1359. doi:10.1001/archopht.119.9.1354.; Risk factors associated with age-related macular degenerationA case-control study in the age-related eye disease study: age-related eye disease study report Age-Related Eye Disease Study Research Group. Ophthalmology. 2000;107(3):2224–2232. doi:10.1016/s0161-6420(00)00409-7.; Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, Nickerson RS, The Framingham Eye Study. I. Outline and major prevalence findings. Am. J. Epidemiol. 1977;106:17–32. doi:10.1093/oxfordjournals.aje.a112428.; Duan Y, Mo J, Klein R, Scott IU, Lin HM, Caulfield J, Age-related macular degeneration is associated with incident myocardial infarction among elderly Americans. Ophthalmology. 2007;114:732–737. doi:10.1016/j.ophtha.2006.07.045.; Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MO. Factors associated with agerelated macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol. 1988;128:700-710. doi:10.1093/oxfordjournals.aje.a115023.; Sperduto RD, Hiller R. Systemic hypertension and age-related maculopathy in the Framingham Study. Arch. Ophthalmol. 1986;104:216–219. doi:10.1001/archopht.1986.01050140070022.; Hyman L, Schachat AP, He Q, Leske MC. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch.Ophthalmol. 2000;118:351–358. doi:10.1001/archopht.118.3.351.; Klein R, Klein BE, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 2003;110:1273–1278 . doi:10.1001/archopht.118.3.351.; Klein R, Deng Y, Klein BE, Hyman L, Seddon J, Frank RN. Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Wom‐AMD: Epidemiology and Risk Factors 31 en’s Health Initiative Sight Exam ancillary study. Am.J Ophthalmol. 2007;143:473–483. doi:10.1016/j.ajo.2006.11.058.; Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, Risk factors for agerelated macular degeneration: Pooled findings from three continents. Ophthalmology. 2001;108:697–704. doi:10.1016/s0161-6420(00)00580-7.; Hyman LG, Lilienfeld AM, Ferris FL III, Fine SL. Senile macular degeneration: a case-control study. Am. J. Epidemiol. 1983;118:213–227. doi:10.1093/oxfordjournals.aje.a113629.; Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL. III. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report Ophthalmology. 2005;112(19):533–559. doi:10.1016/j.ophtha.2004.10.047.; Vinding T, Appleyard M, Nyboe J, Jensen G. Risk factor analysis for atrophic and exudative age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol. (Copenh). 1992;70:66–72. doi:10.1111/j.17553768.1992.tb02093.x.; Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch.Ophthalmol. 1998;116:583–587. doi:10.1001/archopht.116.5.583.; Klein R, Clegg L, Cooper LS, Hubbard LD, Klein BE, King WN. Prevalence of agerelated maculopathy in the Atherosclerosis Risk in Communities Study. Arch. Ophthalmol. 1999;117:1203–1210. doi:10.1001/archopht.117.9.1203.; Delcourt C, Diaz JL, Ponton-sanchez A, Papoz L. Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liees a l’Age. Arch. Ophthalmol. 1998;116:1031–1035. doi:10.1001/archopht.116.8.1031.; Klein R, Klein BE, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 2003;110:1273–1280. doi:10.1016/S01616420(03)00599-2.; Tomany SC, Wang JJ, Van Leeuwen R, Klein R, Mitchell P, Vingerling JR, Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology. 2004;111:1280–1287. DOI:10.1016/j.ophtha.2003.11.010; Buch H, Vinding T, la Cour M, Jensen GB, Prause JU, Nielsen NV. Risk factors for age-related maculopathy in a 14-year follow-up study: the Copenhagen City Eye Study. Acta Ophthalmol. Scand. 2005;83:409–418. doi:10.1111/j.16000420.2005.00492.x.; Xu L, Li Y, Zheng Y, Jonas JB. Associated factors for age related maculopathy in the adult population in China: the Beijing eye study. Br. J Ophthalmol. 2006;90:1087– 1090. doi:10.1136/bjo.2006.096123.; Mccarty CA, Mukesh BN, Fu CL, Mitchell P, Wang JJ, Taylor HR. Risk factors for age-related maculopathy: the Visual Impairment Project. Arch. Ophthalmol. 2001;119:1455–1462. doi:10.1001/archopht.119.10.1455.; Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch. Ophthalmol. 2003;121:785–972. doi:10.1001/archopht.121.6.785.; Krishnaiah S, Das T, Nirmalan PK, Nutheti R, Shamanna BR, Rao GN. Risk factors for age-related macular degeneration: findings from the Andhra Pradesh eye disease study in South India. Invest Ophthalmol. Vis. Sci. 2005;46:4442–4449. doi:10.1167/iovs.05-0853.; Leske MC, Wu SY, Hennis A, Nemesure B, Yang L, Hyman L, Nine-year incidence of age-related macular degeneration in the Barbados Eye Studies. Ophthalmology. 2006;113:29–35. doi:10.1016/j.ophtha.2005.08.012.; Blumenkranz MS, Russell SR, Robey MG, Kott-blumenkranz R, Penneys N. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology. 1986;93:552–558. doi:10.1016/s0161-6420(86)33702-3.; Klein R, Klein BE, Jensen SC. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997;104:1804–1812. doi:10.1016/s0161-6420(97)30023-2.; Spaide RF, Jaffe GJ. Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data. Ophthalmology. 2020;127:616–636. doi:10.1016/j.ophtha.2019.11.004.; Нероев ВВ, Коротких СА., Бобыкин ЕВ. Информационный лифлет для пациентов, получающих лечение с применением интравитреального введения лекарственных препаратов. Рекомендации Экспертного совета по заболеваниям сетчатки и зрительного нерва Общероссийской общественной организации «Ассоциация врачей офтальмологов». Российский офтальмологический журнал. 2021;14(S2):7–19; Barış ME, Menteş J, Afrashi F. Subgroups and Features of Poor Responders to Anti-Vascular Endothelial Growth Factor Treatment in Eyes with Neovascular Age-Related Macular Degeneration. Turk J Ophthalmol. 2020;50(5):275–282. doi:10.4274/tjo.galenos.2020.38488.; Liew G, Mitchell P, Leeder SR, Smith W, Wong TY, Wang JJ. Regular aspirin use and retinal microvascular signs: the Blue Mountains Eye Study. Journal of hypertension. 2006;24(7):1329–1335. doi:10.1097/01.hjh.0000234113.33025.33.; Yun C, Ahn J, Kim M, Hwang S-Y, Kim S-W, Oh J. Ocular perfusion pressure and choroidal thickness in early age-related macular degeneration patients with reticular pseudodrusen. Investigative ophthalmology & visual science. 2016;57(15):6604– 6609. doi:10.1167/iovs.16-19989.; Katsi VK, Marketou ME, Vrachatis DA, Manolis AJ, Nihoyannopoulos P, Tousoulis D, Vardas PE, Kallikazaros I. Essential hypertension in the pathogenesis of agerelated macular degeneration: a review of the current evidence. Journal of hypertension. 2015;33(12):2382–2388. doi:10.1097/HJH.0000000000000766.; Blumenfeld JD, Laragh JH. Renin system analysis: a rational method for the diagnosis and treatment of the individual patient with hypertension. American journal of hypertension. 1998;11(7):894–896. doi:10.1016/s0895-7061(98)00080-6.; Barro-Soria R, Stindl J, Müller C, Foeckler R, Todorov V, Castrop H, Angiotensin2-mediated Ca 2+ signaling in the retinal pigment epithelium: role of angiotensinreceptor-associated-protein and TRPV2 channel. PLoS one. 2012;7(11):e49624. doi:10.1371/journal.pone.0049624.; Hikichi T, Mori F, Takamiya A, Sasaki M, Horikawa Y, Takeda M, Inhibitory effect of losartan on laser-induced choroidal neovascularization in rats. American journal of ophthalmology. 2001;132(4):587–589. doi:10.1016/s0002-9394(01)01139-4.; Vidaurri JS, Pe’er J, Halfon ST, Association between drusen and some of the risk factors for coronary artery disease. Ophthalmologica. 1984;188:243–247. doi:10.1159/000309370.; Klein R, Klein BE, Franke T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1993;100:406–414. doi:10.1016/s0161-6420(93)31634-9.; https://www.ophthalmojournal.com/opht/article/view/2301Test

الإتاحة: https://doi.org/10.18008/1816-5095-2024-1-117-127Test
https://doi.org/10.18008/1816-5095-2024-1Test
https://doi.org/10.1001/archopht.1986.01050140070022Test
https://doi.org/10.1016/S01616420Test(02)01448-3
https://doi.org/10.1016/j.ophtha.2006.09.033Test
https://doi.org/10.1016/j.ophtha.2014.03.022Test
https://doi.org/10.1001/archopht.119.9.1354Test
https://doi.org/10.1016/s0161-6420Test(00)00409-7
https://doi.org/10.1093/oxfordjournals.aje.a112428Test
https://doi.org/10.1016/j.ophtha.2006.07.045Test

المؤلفون: V. G. Likhvantseva, A. S. Gevorgyan, S. G. Kapkova, S. I. Rychkova, T. E. Borisenko, В. Г. Лихванцева, А. С. Геворкян, С. Г. Капкова, С. И. Рычкова, Т. Е. Борисенко

المصدر: Ophthalmology in Russia; Том 21, № 1 (2024); 128-137 ; Офтальмология; Том 21, № 1 (2024); 128-137 ; 2500-0845 ; 1816-5095 ; 10.18008/1816-5095-2024-1

مصطلحات موضوعية: ожирение, antiangiogenic therapy, risk factor for poor response to treatment, obesity, антиангиогенная терапия, фактор риска плохо ответа на лечение

وصف الملف: application/pdf

العلاقة: https://www.ophthalmojournal.com/opht/article/view/2302/1196Test; Kai JY, Zhou M, Li DL, Zhu KY, Wu Q, Zhang XF, Pan CW. Smoking, dietary factors and major age-related eye disorders: an umbrella review of systematic reviews and metaanalyses Br J Ophthalmol. 2023 Dec 18;108(1):51–57. doi:10.1136/bjo-2022-322325; Шиган ЕЕ. История возникновения понятия «риск здоровью» и его место в развитии профилактической медицины. Журнал «Анализ риска здоровью». 2016;2:4–9. doi:10.21668/health.risk/2016.2.01.; Tomany SC, Wang JJ, Van Leeuwen R, Klein R, Mitchell P, Vingerling JR, Klein BE, Smith W, De Jong PT. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology. 2004;111(7):1280–1287. doi:10.1016/j.ophtha.2003.11.010.; Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia: the blue mountains eye study. Ophthalmology. 1995;102(10):1450– 1460. doi:10.1016/s0161-6420(95)30846-9.; Mitchell P, Wang JJ, Foran S, Smith W. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology. 2002;109(6):1092– 1097. doi:10.1016/s0161-6420(02)01055-2.; Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, Hofman A, Jensen S, Wang JJ, de Jong PT. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology. 2001;108(4):697–704. doi:10.1016/s0161-6420(00)00580-7.; Klaver CC, Assink JJ, van Leeuwen R, Wolfs RC, Vingerling JR, Stijnen T, Hofman A, de Jong PT. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Investigative Ophthalmology & Visual Science. 2001;42(10):2237–2241.; van Leeuwen R, Klaver CCW, Vingerling JR, Hofman A, de Jong PTVM. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Archives of Ophthalmology. 2003;121(4):519–526. doi:10.1001/archopht.121.4.519.; Delcourt C, Cristol J-P, Tessier F, Léger CL, Descomps B, Papoz L. Age-related macular degeneration and antioxidant status in the POLA study. Archives of Ophthalmology. 1999;117(10):1384–1390. doi:10.1001/archopht.117.10.1384.; Delcourt C, Lacroux A, Carrière I. The three-year incidence of age-related macular degeneration: the “pathologies Oculaires Liées à l’Age” (POLA) prospective study. American Journal of Ophthalmology. 2005;140(5):924–926. doi:10.1016/j.ajo.2005.05.002.; Varma R, Fraser-Bell S, Tan S, Klein R, Azen SP. Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study. Ophthalmology. 2004;111(7):1288–1297. doi:10.1016/j.ophtha.2004.01.023.; Arnarsson A, Sverrisson T, Stefánsson E, Sigurdsson H, Sasaki H, Sasaki K, Jonasson F. Risk factors for five-year incident age-related macular degeneration: the Reykjavik Eye Study. American Journal of Ophthalmology. 2006;142(3):419–428.e1. doi:10.1016/j.ajo.2006.04.015.; Jonasson F, Arnarsson A, Peto T, Sasaki H, Sasaki K, Bird AC. 5-year incidence of age-related maculopathy in the Reykjavik Eye Study. Ophthalmology. 2005;112(1):132–138. doi:10.1016/j.ophtha.2004.07.020.; Xu L, Li Y, Zheng Y, Jonas JB. Associated factors for age related maculopathy in the adult population in China: the Beijing eye study. British Journal of Ophthalmology. 2006;90(9):1087–1090. doi:10.1136/bjo.2006.096123.; Buch H, Nielsen NV, Vinding T, Jensen GB, Prause JU, La Cour M. 14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study. Ophthalmology. 2005;112(5):787–798. doi:10.1016/j.ophtha.2004.11.040.; Buch H, Vinding T, La Cour M, Jensen GB, Prause JU, Nielsen NV. Risk factors for age-related maculopathy in a 14-year follow-up study: the Copenhagen City Eye Study. Acta Ophthalmologica Scandinavica. 2005;83(4):409–418. doi:10.1111/j.16000420.2005.00492.x.; Krishnaiah S, Das T, Nirmalan PK, Nutheti R, Shamanna BR, Rao GN, Thomas R Risk factors for age-related macular degeneration: findings from the Andhra Pradesh Eye Disease Study in south India. Investigative Ophthalmology & Visual Science. 2005;46(12):4442–4449. doi:10.1167/iovs.05-0853.; Miyazaki M, Kiyohara Y, Yoshida A, Iida M, Nose Y, Ishibashi T. The 5-year incidence and risk factors for age-related maculopathy in a general Japanese population: the Hisayama study. Investigative Ophthalmology & Visual Science. 2005;46(6):1907–1910. doi:10.1167/iovs.04-0923.; Miyazaki M, Nakamura H, Kubo M, Kiyohara Y, Oshima Y, Ishibashi T, Nose Y. Risk factors for age related maculopathy in a Japanese population: the Hisayama study. British Journal of Ophthalmology. 2003;87(4):469–472. doi:10.1136/bjo.87.4.469.; McCarty CA, Mukesh BN, Fu CL, Mitchell P, Wang JJ, Taylor HR. Risk factors for age-related maculopathy: the visual impairment project. Archives of Ophthalmology. 2001;119(10):1455–1462. doi:10.1001/archopht.119.10.1455.; Mukesh BN, Dimitrov PN, Leikin S, Wang JJ, Mitchell P, McCarty CA, Taylor HR. Five-year incidence of age-related maculopathy: the Visual Impairment Project. Ophthalmology. 2004;111(6):1176–1182. doi:10.1016/j.ophtha.2003.08.042.; Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, Waheed NK, Chakravarthy U, Rosenfeld PJ, Holz FG, Souied EH, Cohen SY, Querques G, OhnoMatsui K, Boyer D, Gaudric A, Blodi B, Baumal CR, Li X, Coscas GJ, Brucker A, Singerman L, Luthert P, Schmitz-Valckenberg S, Schmidt-Erfurth U, Grossniklaus HE, Wilson DJ, Guymer R, Yannuzzi LA, Chew EY, Csaky K, Monés JM, Pauleikhoff D, Tadayoni R, Fujimoto J. Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data. Ophthalmology. 2020; 127: 616–636. doi:10.1016/j.ophtha.2019.11.004.; Нероев ВВ, Коротких СА, Бобыкин ЕВ, Зайцева ОВ. Информационный лифлет для пациентов, получающих лечение с применением интравитреального введения лекарственных препаратов. Рекомендации Экспертного совета по заболеваниям сетчатки и зрительного нерва Общероссийской общественной организации «Ассоциация врачей офтальмологов». Российский офтальмологический журнал. 2021;14(S2):7–19.; Barış ME, Menteş J, Afrashi F. Subgroups and Features of Poor Responders to AntiVascular Endothelial Growth Factor Treatment in Eyes with Neovascular Age-Related Macular Degeneration. Turk J Ophthalmol. 2020;50(5):275–282. doi:10.4274/tjo.galenos.2020.38488.; De Lorenzo A, Del Gobbo V, Premrov MG, Bigioni M, Galvano F, Di Renzo L. Normal-weight obese syndrome: early inflammation? The American Journal of Clinical Nutrition. 2007;85(1):40–45. doi:10.1093/ajcn/85.1.40.; Schaumberg DA, Christen WG, Hankinson SE, Glynn RJ. Body mass index and the incidence of visually significant age-related maculopathy in men. Archives of Ophthalmology. 2001;119(9):1259–1265. doi:10.1001/archopht.119.9.1259.; Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Archives of Ophthalmology. 2003;121(6):785–792. doi:10.1001/archopht.121.6.785.; Friedman E. The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. American Journal of Ophthalmology. 2000 ;130(5):658– 663. doi:10.1016/s0002-9394(00)00643-7.; Friedman E. A hemodynamic model of the pathogenesis of age-related macular degeneration. American Journal of Ophthalmology. 1997;124(5):677–682. doi:10.1016/s0002-9394(14)70906-7.; Klein BEK, Klein R, Jensen SC, Ritter LL, Burton TC. Are sex hormones associated with age-related maculopathy in women? The Beaver Dam Eye Study. Transactions of the American Ophthalmological Society. 1994;92:289–297.; Klein BEK, Klein R, Lee KE. Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women: the Beaver Dam Eye Study. American Journal of Ophthalmology. 2000;130(3):322–326. doi:10.1016/s0002-9394(00)00474-8.; Defay R, Delcourt C, Ranvier M, Lacroux A, Papoz L. Relationships between physical activity, obesity and diabetes mellitus in a French elderly population: the POLA study. Liées à l’Age. International Journal of Obesity. 2001;25(4):512–518. doi:10.1038/sj.ijo.0801570.; Nolan JM, Stack J, O’Connell E, Beatty S. The relationships between macular pigment optical density and its constituent carotenoids in diet and serum. Investigative Ophthalmology & Visual Science. 2007;48(2):571–582. doi:10.1167/iovs.06-0864.; Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 1998; 116: 583–587. doi:10.1001/archopht.116.5.583.; Klein BE, Klein R, Lee KE, Jensen SC. Measures of obesity and age-related eye diseases. Ophthalmic Epidemiol. 2001;8:251–262 doi:10.1076/opep.8.4.251.1612.; Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL. III. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report. Ophthalmology. 2005;112(19):533–539. doi:10.1016/j.ophtha.2004.10.047.; Klein R, Klein BE, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 2003;110:1273–1280. doi:10.1016/S0161-6420(03)00599-2.; Schaumberg DA, Christen WG, Hankinson SE, Glynn RJ. Body mass index and the incidence of visually significant age-related maculopathy in men. Arch. Ophthalmol. 2001:119:1259–1265. doi:10.1001/archopht.119.9.1259.; Klein R, Deng Y, Klein BE, Hyman L, Seddon J, Frank RN, Wallace RB, Hendrix SL, Kuppermann BD, Langer RD, Kuller L, Brunner R, Johnson KC, Thomas AM, Haan M. Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women’s Health Initiative Sight Exam ancillary study. Am J Ophthalmol. 2007 Mar;143(3):473-83. doi:10.1016/j.ajo.2006.11.058; Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch. Ophthalmol. 2003;121:785–792. doi:10.1001/archopht.121.6.785.; Dongre Manoj B. Correlation study of modifiable risk factors and age related Maculopathy Indian. Journal of Clinical and Experimental Ophthalmology. 2017;3(2):132–137. doi:10.18231/2395-1451.2017.0034.; Nolan J, O’Donovan O, Kavanagh H, Stack J, Harrison M, Muldoon A, Mellerio J, Beatty S. . Macular pigment and percentage of body fat. Investigative Ophthalmology & Visual Science. 2004;45(11):3940–3950. doi:10.1167/iovs.04-0273.; Christen WG, Glynn RJ, Manson JE, Ajani UA, Buring JE. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. Journal of the American Medical Association. 1996;276(14):1147–1151.; Athyros VG, Kakafika AI, Karagiannis A, Mikhailidis DP. Do we need to consider inflammatory markers when we treat atherosclerotic disease? Atherosclerosis. 2008;200(1):1–12. doi:10.1016/j.atherosclerosis.2008.02.026.; Wilund KR. Is the anti-inflammatory effect of regular exercise responsible for reduced cardiovascular disease? Clinical Science. 2007;112(11–12):543–555. doi:10.1042/CS20060368.; Smith JK. Exercise and atherogenesis. Exercise and Sport Sciences Reviews. 2001; 29(2):49–53. doi:10.1097/00003677-200104000-00002.; Smith JK, Dykes R, Douglas JE, Krishnaswamy G, Berk S. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. Journal of the American Medical Association. 1999;281(18):1722–1727. doi:10.1001/jama.281.18.1722.; Knudtson MD, Klein R, Klein BEK. Physical activity and the 15-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. British Journal of Ophthalmology. 2006;90(12):1461–1463. doi:10.1136/bjo.2006.103796.; Connell PP,Keane PA, O’Neill EC, Altaie RW, Loane E, Neelam K, Nolan JM, Beatty S. Risk Factors for Age-Related Maculopathy. J Ophthalmol. 2009;2009: 360764. doi:10.1155/2009/360764.; https://www.ophthalmojournal.com/opht/article/view/2302Test

الإتاحة: https://doi.org/10.18008/1816-5095-2024-1-128-137Test
https://doi.org/10.18008/1816-5095-2024-1Test
https://doi.org/10.1136/bjo-2022-322325Test
https://doi.org/10.21668/health.risk/2016.2.01Test
https://doi.org/10.1016/j.ophtha.2003.11.010Test
https://doi.org/10.1016/s0161-6420Test(95)30846-9
https://doi.org/10.1016/s0161-6420Test(02)01055-2
https://doi.org/10.1016/s0161-6420Test(00)00580-7
https://doi.org/10.1001/archopht.121.4.519Test
https://doi.org/10.1001/archopht.117.10.1384Test

المؤلفون: Ruoxue Cai, Ying Liu, Huanhuan Sha, Jingjing Yu, Ying Fang, Guoren Zhou, Bo Shen

المصدر: Heliyon, Vol 9, Iss 11, Pp e21902- (2023)

مصطلحات موضوعية: Pulmonary sarcomatoid carcinoma, Immunotherapy, Antiangiogenic therapy, Radiotherapy, Tislelizumab, Anlotinib, Science (General), Q1-390, Social sciences (General), H1-99

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2405844023091107Test; https://doaj.org/toc/2405-8440Test

الوصول الحر: https://doaj.org/article/4323e9a4d36f490b921b92d5141655c4Test

المؤلفون: Li H, Su K, Guo L, Jiang Y, Xu K, Gu T, Chen J, Wu Z, Wang P, Zhang X, Yan Y, Li S, Wu X, Han L, He K, Wen L, Li B, Han Y

المصدر: Journal of Hepatocellular Carcinoma, Vol Volume 10, Pp 1257-1266 (2023)

مصطلحات موضوعية: hcc, pd-1 inhibitors, antiangiogenic therapy, tace, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/pd-1-inhibitors-combined-withTest-antiangiogenic-therapy-with-or-without-t-peer-reviewed-fulltext-article-JHC; https://doaj.org/toc/2253-5969Test

الوصول الحر: https://doaj.org/article/e8d1f72c04da49c3955465f97d203dc9Test